Recent Finacing
Recent Raise
Glen Clova Scientific develops a virus-like particle platform and preclinical biologic candidates for chronic inflammatory and autoimmune diseases, advancing assets and pursuing platform partnerships across pharmaceutical and non-pharmaceutical markets.
